Societal CDMO Signs Multiple Project Expansion Agreements With Existing Customers

Jun 02, 2023

Posted by Societal CDMO

Societal CDMO Selected by Longboard Pharmaceuticals to Provide CDMO Services to Support Clinical Development of LP352

Jun 02, 2023

Posted by Societal CDMO

Societal CDMO Announces U.S. FDA Approval for Manufacturing of Commercial Tablet at Gainesville, Georgia Site

Jun 02, 2023

Posted by Societal CDMO

Freshfields Advises SERB Pharmaceuticals on its U.S. Partnership with SFJ Pharmaceuticals

Jun 01, 2023

Posted by Freshfields

Key Takeaways from the 21st Annual Biomed Israel Conference

Jun 01, 2023

Posted by Freshfields

Ongoing Initiatives at the USPTO and FDA and Their Potential Impact on the Life Sciences Industry in the United States

Jun 01, 2023

Posted by Freshfields

FTC v. Amgen/Horizon: FTC’s Pursuit of a Novel Theory Signals Greater Scrutiny on the Horizon for Pharmaceutical Mergers

Jun 01, 2023

Posted by Freshfields

Veristat Taps Accomplished Industry Leaders to Support Growth and Innovation

May 23, 2023

Posted by Veristat, LLC

Greenberg Traurig Boston Partners with HealthTech Build for Digital Health Panel

May 23, 2023

Posted by Greenberg Traurig, LLP